e-learning
resources
Milan 2017
Monday, 11.09.2017
Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis
B. Urizar Catalan (Huelva, Spain)
Source:
International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Session:
Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Session type:
Poster Discussion
Number:
2034
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Urizar Catalan (Huelva, Spain). Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis. 2034
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Quantitative determination of terbinafine (anti-aspergillar drug ) in human plasma and lung tissue by gas-chromatography and mass spectometry (GC-MS)
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005
Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
Mass spectrometry proteomic biomarkers identify acute COPD exacerbations
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012
Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry.
Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions
Year: 2019
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry
Source: Eur Respir J 2004; 24: Suppl. 48, 213s
Year: 2004
Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010
A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Proteonomic fingerprinting of serum for the detection of tuberculosis
Source: Annual Congress 2009 - Novel diagnostics in tuberculosis
Year: 2009
Ion mobility spectrometry in lung transplant patients
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
The value of rapid speciation of nontuberculous mycobacteria (NTM) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept